arrow
李占国 封面图

李占国 (Zhanguo Li)

Peking University People's Hospital
H指数:54
被引数:2.2万

个人简介

"李占国,博士,教授。2010年毕业于长春理工大学高功率半导体激光国家重点实验室,获工学博士学位。主要从事无机/有机半导体光电子材料及器件研究工作,包括III-V族近红外及中红外GaAs、GaSb基低维量子点、半导体激光器及其器件应用、有机OPVs和OLED微结构光程利用体系的构建,以及半导体太赫兹(THz)激光光源的检测与成像应用技术研究等。\n作为负责人,主持国家级(部委)项目9项(自然基金3项),省部级项目18项(省级重点项目4项);作为骨干参与装备预研基金等10余项。获得省部级科研奖励5项,个人奖励5项,其中以第一完成人身份获得中华人民共和国****发明二等奖1项,出版专著2部,发表论文30篇,第一发明人授权专利6件。"

教育背景

  • 2010.12

    长春理工大学高功率半导体激光国家重点实验室 工学博士学位

工作经历

暂无内容

荣誉奖项

暂无内容

P2X7R of synovial fibroblasts is a potential therapeutic target associated with refractory rheumatoid arthritis

滑膜成纤维细胞的P2X7R是难治性类风湿关节炎的潜在治疗靶点

2026-05-220
OA
Low dose IL-2 therapy restores regulatory T cells in patients with systemic lupus erythematosus in a dose-dependent manner: a phase IIb trial

低剂量IL-2疗法以剂量依赖性方式恢复系统性红斑狼疮患者中的调节性T细胞:一项IIb期试验

2026-04-210
OAAI
Prasugrel inhibits TLR7-driven autoimmunity in systemic lupus erythematosus by acetylating cGAS

普拉格雷尔通过乙酰化cGAS抑制系统性红斑狼疮中的TLR7驱动的自身免疫。

2026-03-180
OAAI
MDA5 regulates BCR signaling and B-cell function via NF-κB-mediated DNM1

MDA5通过NF-κB介导的DNM1调节BCR信号通路和B细胞功能。

2026-01-010
PRE
Predictors of damage accrual by organ domain in systemic lupus erythematosus

系统性红斑狼疮中按器官领域累积损伤的预测因子

2025-12-010
OAAI
Prevalence, Determinants, and Outcomes of Low Disease Activity and Remission Attainment in Patients With Systemic Lupus Erythematosus That Is Clinically Active
2025-12-010
OAAI
Mizoribine or Cyclophosphamide for Lupus Nephritis: A Randomized Clinical Trial

霉酚酸或环磷酰胺治疗狼疮肾炎:一项随机临床试验

2025-03-140
OA
Frequency and Determinants of Flare and Persistently Active Disease in a Large Multinational Prospective Lupus Cohort

系统性红斑狼疮大型跨国前瞻性队列中flare和持续性活动性疾病的频率与决定因素

2025-02-260
OAAI
Time trends of variability in disease activity in systemic lupus erythematosus
2025-02-120
OAAI
Longitudinal associations of flare and damage accrual in patients with systemic lupus erythematosus
2025-01-190
OAAI
Association of sustained lupus low disease activity state with improved outcomes in systemic lupus erythematosus: a multinational prospective cohort study
2024-08-012
PRE